Thus, the dysregulation of AMPK and SIRT1 signaling in obesity not only disrupts metabolic homeostasis but also contributes to associated neurobehavioral and hepatic complications, highlighting their potential as therapeutic targets for metabolic and psychiatric disorders. The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.